![Dow Jones Industrial Average / Pharmacology / Pharmaceuticals policy / Covington & Burling / Exenatide / Eli Lilly / Pfizer / Covington / King Pharmaceuticals / Eli Lilly and Company / Pharmaceutical industry / Pharmaceutical sciences Dow Jones Industrial Average / Pharmacology / Pharmaceuticals policy / Covington & Burling / Exenatide / Eli Lilly / Pfizer / Covington / King Pharmaceuticals / Eli Lilly and Company / Pharmaceutical industry / Pharmaceutical sciences](https://www.pdfsearch.io/img/413b85d2fd36bf5c1f59a6495b6224fc.jpg)
| Document Date: 2012-01-25 10:28:14 Open Document File Size: 288,45 KBShare Result on Facebook
City San Francisco / New York / Beijing / Silicon Valley / Washington / London / San Diego / Brussels / / Company Merck & Co. Inc. / Oceana Therapeutics Inc. / Lilly / Amylin Pharmaceuticals Inc. / Lupin Ltd. / Axis Shield PLC / Portfolio Media Inc. / Pfizer Inc. / Wyeth Inc. / King Pharmaceuticals Inc. / Merck / Alere Inc. / Boehringer Ingelheim GmbH / Health / Covington & Burling LLP / Salix Pharmaceuticals Ltd. / Eli Lilly & Co. / / Country India / / Currency USD / / / Event Business Partnership / M&A / Reorganization / Legal Issues / / / IndustryTerm pharmaceutical industry / life sciences / anti-tuberculosis drug maker / / Person Mike Brock / Richard Kingham / John Hurvitz / Elizabeth Bowen / Derek Hawkins / / / Position group chair / co-chair of the life sciences group / co-chair / / Product Fosamax / Byetta / Tradjenta / / ProvinceOrState New York / California / / URL www.law360.com / /
SocialTag |